The following represents disclosure information provided by authors of this abstract. The program committee has reviewed all presenting author disclosure reports, identified potential conflicts of interest, and implemented strategies to manage those areas of conflict, where appropriate. All relationships are considered compensated. Relationships are self-held unless otherwise noted. I = Immediate Family Member, Inst = My Institution
 
Open Payments is a public database containing information reported by companies about payments made to US-licensed physicians (Open Payments)
 
 
Employment - Bristol-Myers Squibb
Stock and Other Ownership Interests - Bayer; Bristol-Myers Squibb
 
Stock and Other Ownership Interests - Ardelyx; Dynavax Technologies
Honoraria - Incyte
Speakers' Bureau - Agios; Incyte; Novartis
MAGNIFY phase IIIb interim analysis of induction R2 followed by maintenance in relapsed/refractory indolent NHL.
 
David Jacob Andorsky
Honoraria - Abbvie
Research Funding - AstraZeneca (Inst); Celgene (Inst)
 
Morton Coleman
Consulting or Advisory Role - BeiGene
Speakers' Bureau - Janssen; Pharmacyclics
Research Funding - Acerta Pharma; ARMO BioSciences; AstraZeneca; BeiGene; Boston Biomedical; Celgene; Incyte; Karyopharm Therapeutics; Merck; Millennium; Novartis; Pharmacyclics; Puma Biotechnology; Seagen
 
Abdulraheem Yacoub
No Relationships to Disclose
 
Jason M. Melear
Speakers' Bureau - Janssen; Lilly
 
Suzanne R. Fanning
Consulting or Advisory Role - Celgene
Speakers' Bureau - Celgene
 
Kathryn S. Kolibaba
Employment - Compass Oncology
Honoraria - TG Therapeutics
Consulting or Advisory Role - Gilead Sciences
Research Funding - Acerta Pharma (Inst); Celgene (Inst); Cell Therapeutics (Inst); Genentech/Roche (Inst); Gilead Sciences (Inst); Janssen (Inst); Novartis (Inst); Pharmacyclics (Inst); Seagen (Inst); TG Therapeutics (Inst)
Travel, Accommodations, Expenses - TG Therapeutics
 
Frederick Lansigan
Consulting or Advisory Role - Celgene; Seagen; Spectrum Pharmaceuticals
Research Funding - Spectrum Pharmaceuticals (Inst)
 
Chris Reynolds
No Relationships to Disclose
 
Grzegorz S. Nowakowski
Consulting or Advisory Role - Celgene (Inst); Genentech (Inst); MorphoSys (Inst)
Research Funding - Celgene (Inst); MorphoSys (Inst); NanoString Technologies (Inst)
 
Mecide Gharibo
No Relationships to Disclose
 
Jung Ryun Ahn
Employment - Bristol-Myers Squibb
Stock and Other Ownership Interests - Bristol-Myers Squibb
 
Ju Li
Employment - Bristol-Myers Squibb
Stock and Other Ownership Interests - Bristol-Myers Squibb
Research Funding - Bristol-Myers Squibb (Inst)
Travel, Accommodations, Expenses - Bristol-Myers Squibb
 
Mathias J. Rummel
Honoraria - Amgen; Celgene; Roche
Research Funding - Roche (Inst)
 
Jeff P. Sharman
Leadership - US Oncology
Consulting or Advisory Role - Abbvie; Acerta Pharma/AstraZeneca; Celgene; Genentech; Pharmacyclics; TG Therapeutics
Research Funding - Acerta Pharma (Inst); Celgene (Inst); Genentech (Inst); Gilead Sciences (Inst); Merck (Inst); Pharmacyclics (Inst); Seagen (Inst); Takeda (Inst); TG Therapeutics (Inst)
Expert Testimony - Gilead Sciences